{"disease":{"id":"neoplasm-recurrence-local","name":"neoplasm recurrence local"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05475288","title":"Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":3554,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT05475301","title":"Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":1431,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT02801409","title":"Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT03583619","title":"Randomized Trial of Accelerated Partial Breast Irradiation","phase":"NA","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06441110","title":"Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT06942416","title":"Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Shandong Cancer Hospital and Institute","has_results":false},{"nct_id":"NCT06912087","title":"Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"University of Chicago","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}